BrightAccountsProduction v1.0.0 v1.0.0 2024-04-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company is the preparation and retail of pharmaceutical and medicinal products. 28 August 2025 NI068578 2025-03-31 NI068578 2024-03-31 NI068578 2023-03-31 NI068578 2024-04-01 2025-03-31 NI068578 2023-04-01 2024-03-31 NI068578 uk-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 NI068578 uk-curr:PoundSterling 2024-04-01 2025-03-31 NI068578 uk-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 NI068578 uk-bus:FullAccounts 2024-04-01 2025-03-31 NI068578 uk-core:ShareCapital 2025-03-31 NI068578 uk-core:ShareCapital 2024-03-31 NI068578 uk-core:RetainedEarningsAccumulatedLosses 2025-03-31 NI068578 uk-core:RetainedEarningsAccumulatedLosses 2024-03-31 NI068578 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-03-31 NI068578 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2024-03-31 NI068578 uk-bus:FRS102 2024-04-01 2025-03-31 NI068578 uk-core:Goodwill 2024-04-01 2025-03-31 NI068578 uk-core:LandBuildings 2024-04-01 2025-03-31 NI068578 uk-core:PlantMachinery 2024-04-01 2025-03-31 NI068578 uk-core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 NI068578 uk-core:MotorVehicles 2024-04-01 2025-03-31 NI068578 uk-core:Goodwill 2024-03-31 NI068578 uk-core:Goodwill 2025-03-31 NI068578 uk-core:CostValuation 2025-03-31 NI068578 uk-core:CurrentFinancialInstruments 2025-03-31 NI068578 uk-core:CurrentFinancialInstruments 2024-03-31 NI068578 uk-core:WithinOneYear 2025-03-31 NI068578 uk-core:WithinOneYear 2024-03-31 NI068578 uk-core:WithinOneYear 2025-03-31 NI068578 uk-core:WithinOneYear 2024-03-31 NI068578 uk-core:AfterOneYear 2025-03-31 NI068578 uk-core:AfterOneYear 2024-03-31 NI068578 uk-core:BetweenOneTwoYears 2025-03-31 NI068578 uk-core:BetweenOneTwoYears 2024-03-31 NI068578 uk-core:BetweenTwoFiveYears 2025-03-31 NI068578 uk-core:BetweenTwoFiveYears 2024-03-31 NI068578 uk-core:MoreThanFiveYears 2025-03-31 NI068578 uk-core:MoreThanFiveYears 2024-03-31 NI068578 2024-04-01 2025-03-31 NI068578 uk-bus:Director1 2024-04-01 2025-03-31 NI068578 uk-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Company Registration Number: NI068578
 
 
Meigh Pharmacy Limited
 
Unaudited Financial Statements
 
for the financial year ended 31 March 2025
Meigh Pharmacy Limited
Company Registration Number: NI068578
BALANCE SHEET
as at 31 March 2025

2025 2024
Notes £ £
 
Fixed Assets
Intangible assets 4 4,027,417 4,474,908
Tangible assets 5 311,267 352,029
Investments 6 323,314 323,314
───────── ─────────
Fixed Assets 4,661,998 5,150,251
───────── ─────────
 
Current Assets
Stocks 7 160,000 160,000
Debtors 8 146,025 172,590
Cash and cash equivalents 123,696 93,041
───────── ─────────
429,721 425,631
───────── ─────────
Creditors: amounts falling due within one year 9 (1,454,134) (1,294,182)
───────── ─────────
Net Current Liabilities (1,024,413) (868,551)
───────── ─────────
Total Assets less Current Liabilities 3,637,585 4,281,700
 
Creditors:
amounts falling due after more than one year 10 (2,990,359) (3,206,033)
───────── ─────────
Net Assets 647,226 1,075,667
═════════ ═════════
 
Capital and Reserves
Called up share capital 1 1
Retained earnings 647,225 1,075,666
───────── ─────────
Equity attributable to owners of the company 647,226 1,075,667
═════════ ═════════
 

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

           
The company has taken advantage of the exemption under section 444 not to file the Profit and Loss Account and Director's Report.
           
For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 28 August 2025
           
           
________________________________          
Richard Garvey          
Director          
           



Meigh Pharmacy Limited
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 31 March 2025

   
1. General Information
 
Meigh Pharmacy Limited is a company limited by shares incorporated in Northern Ireland. 42 Dernaroy Road, Killeavy, Newry, Co. Armagh, BT35 8SP, United Kingdom is the registered office, which is also the principal place of business of the company. . The nature of the company's operations and its principal activities are set out in the Director's Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance

The financial statements of the company for the year ended 31 March 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.

 
Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

 
Consolidated accounts
The company is entitled to the exemption in Section 399 of the Companies Act 2006 from the obligation to prepare group accounts.
 
Turnover
Turnover represents the total invoice value, excluding value added tax, of sales made during the year. Revenue is recognised at the point of sale.
 
Goodwill

Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Balance Sheet and amortised on a straight line basis over its economic useful life of 10 years, which is estimated to be the period during which benefits are expected to arise.  On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.

 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Land and buildings freehold - 4% Straight line
  Plant and machinery - 15% Straight line
  Fixtures, fittings and equipment - 20% Reducing Balance
  Motor vehicles - 25% straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Investments
Investments held as fixed assets are stated at cost less provision for any permanent diminution in value. Income from other investments together with any related tax credit is recognised in the Profit and Loss Account in the year in which it is receivable.
 
Stocks
Stocks are valued at the lower of cost and net realisable value.  Cost comprises expenditure incurred in the normal course of business in bringing stocks to their present location and condition.  Full provision is made for obsolete and slow moving items.  Net realisable value comprises actual or estimated selling price (net of trade discounts) less all further costs to completion or to be incurred in marketing and selling.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Borrowing costs
Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 22, (2024 - 22).
 
  2025 2024
  Number Number
 
Director 1 1
Shop Staff 21 21
  ───────── ─────────
  22 22
  ═════════ ═════════
       
4. Intangible assets
     
  Goodwill Total
  £ £
Cost
At 1 April 2024 4,824,908 4,824,908
  ───────── ─────────
 
At 31 March 2025 4,824,908 4,824,908
  ───────── ─────────
Amortisation
At 1 April 2024 350,000 350,000
Charge for financial year 447,491 447,491
  ───────── ─────────
At 31 March 2025 797,491 797,491
  ───────── ─────────
Net book value
At 31 March 2025 4,027,417 4,027,417
  ═════════ ═════════
At 31 March 2024 4,474,908 4,474,908
  ═════════ ═════════
             
5. Tangible assets
  Land and Plant and Fixtures, Motor Total
  buildings machinery fittings and vehicles  
  freehold   equipment    
  £ £ £ £ £
Cost
At 1 April 2024 236,020 228,288 164,363 58,760 687,431
Additions - - 3,090 15,500 18,590
  ───────── ───────── ───────── ───────── ─────────
At 31 March 2025 236,020 228,288 167,453 74,260 706,021
  ───────── ───────── ───────── ───────── ─────────
Depreciation
At 1 April 2024 17,366 148,741 119,926 49,369 335,402
Charge for the financial year 2,338 34,243 9,505 13,266 59,352
  ───────── ───────── ───────── ───────── ─────────
At 31 March 2025 19,704 182,984 129,431 62,635 394,754
  ───────── ───────── ───────── ───────── ─────────
Net book value
At 31 March 2025 216,316 45,304 38,022 11,625 311,267
  ═════════ ═════════ ═════════ ═════════ ═════════
At 31 March 2024 218,654 79,547 44,437 9,391 352,029
  ═════════ ═════════ ═════════ ═════════ ═════════
       
6. Investments
  Group and Total
  participating  
  interests/  
  joint ventures  
Investments £ £
Cost
 
At 31 March 2025 323,314 323,314
  ───────── ─────────
Net book value
At 31 March 2025 323,314 323,314
  ═════════ ═════════
At 31 March 2024 323,314 323,314
  ═════════ ═════════
       
7. Stocks 2025 2024
  £ £
 
Finished goods and goods for resale 160,000 160,000
  ═════════ ═════════
 
The replacement cost of stock did not differ significantly from the figures shown.
       
8. Debtors 2025 2024
  £ £
 
Trade debtors 123,867 136,344
Other debtors 2,125 22,839
Taxation  (Note 11) 16,500 11,407
Prepayments and accrued income 3,533 2,000
  ───────── ─────────
  146,025 172,590
  ═════════ ═════════
       
9. Creditors 2025 2024
Amounts falling due within one year £ £
 
Bank loan 339,024 456,364
Trade creditors 209,339 243,541
Amounts owed to group undertakings 609,251 359,562
Taxation  (Note 11) 21,089 15,935
Director's current account 270,931 186,780
Accruals 4,500 32,000
  ───────── ─────────
  1,454,134 1,294,182
  ═════════ ═════════
       
10. Creditors 2025 2024
Amounts falling due after more than one year £ £
 
Bank loan 2,750,359 2,806,033
Other loans 240,000 400,000
  ───────── ─────────
  2,990,359 3,206,033
  ═════════ ═════════
 
Loans
Repayable in one year or less, or on demand (Note 9) 339,024 456,364
Repayable between one and two years 678,048 360,000
Repayable between two and five years 1,314,144 1,080,000
Repayable in five years or more 758,167 1,366,033
  ───────── ─────────
  3,089,383 3,262,397
  ═════════ ═════════
 
       
11. Taxation 2025 2024
  £ £
 
Debtors:
VAT 16,500 11,407
  ═════════ ═════════
Creditors:
Corporation tax 18,035 12,189
PAYE / NI 3,054 3,746
  ───────── ─────────
  21,089 15,935
  ═════════ ═════════
           
12. Related party transactions
The company has availed of the exemption under FRS 102 Section 1A in relation to the disclosure of transactions with group undertakings.